Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ERVH-6 - Docetaxel resistant prostate cancer cell line
GEO DataSets Gene Profile neighbors
ERVH-6 - Type 2 diabetes and role of hepatokines
ERVH-6 - Lysophosphatidic acid effect on breast and prostate cancer cell lines
ERVH-6 - Pancreatic islet-like cell clusters derived from T3 embryonic stem cells
ERVH-6 - X-linked inhibitor of apoptosis XIAP depletion effect on a colorectal cancer cell line
ERVH-6 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
ERVH-6 - Human epidermal growth factor receptor 2-positive breast cancer brain metastases
ERVH-6 - Tumor suppressor PTEN depletion effect on various cell lines
ERVH-6 - NOTCH antagonist SAHM1 effect on T-ALL cell lines
ERVH-6 - Epidermal injury model
ERVH-6 - Transcription factors YY2 and YY1 knockdown effect on HeLa cells
ERVH-6 - Cyclin-dependent kinase inhibitor R547 effect on colon cancer cell line: dose response and time course
ERVH-6 - Primary keratinocyte response to in vitro cytokine exposure
ERVH-6 - IFNβ-1a in vivo treatment effect on CIS multiple sclerosis patients: peripheral blood mononuclear cells
ERVH-6 - Staphylococcal superantigen toxins effect on peripheral blood mononuclear cells
ERVH-6 - miR-221 expression effect on prostate cancer cell line
ERVH-6 - Telomere-elongated, prostate cancer cells
ERVH-6 - Teratozoospermia (HG-U133 2.0 )
ERVH-6 - Fetal and adult reticulocytes
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on